Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A Life-threatening Combination: Indomethacin and Dabigatran.

Literature DB >> 32428110

A Life-threatening Combination: Indomethacin and Dabigatran.

Adem Adar¹, Orhan Onalan¹, Fahri Cakan¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2020 PMID： 32428110 PMCID： PMC8149119 DOI： 10.36660/abc.20180159

Source DB: PubMed Journal: Arq Bras Cardiol ISSN： 0066-782X Impact factor: 2.000

× No keyword cloud information.

14 in total

1. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Authors: John W Eikelboom; Lars Wallentin; Stuart J Connolly; Mike Ezekowitz; Jeff S Healey; Jonas Oldgren; Sean Yang; Marco Alings; Scott Kaatz; Stefan H Hohnloser; Hans-Christoph Diener; Maria Grazia Franzosi; Kurt Huber; Paul Reilly; Jeanne Varrone; Salim Yusuf
Journal: Circulation Date: 2011-05-16 Impact factor: 29.690

2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors: Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal: Eur J Cardiothorac Surg Date: 2016-09-23 Impact factor: 4.191

3. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression.

Authors: Cai-Guo Ye; William Ka-Kei Wu; John Hok-Keung Yeung; Hai-Tao Li; Zhi-Jie Li; Clover Ching-Man Wong; Shun-Xiang Ren; Lin Zhang; Kwok-Pui Fung; Chi-Hin Cho
Journal: Cancer Lett Date: 2011-03-04 Impact factor: 8.679

4. Hemopericardium and cardiac tamponade associated with dabigatran use.

Authors: Eliza A Dy; Dane L Shiltz
Journal: Ann Pharmacother Date: 2012-07-10 Impact factor: 3.154

5. Hemopericardium in a patient treated with dabigatran etexilate.

Authors: Cassie A Barton; Wesley D McMillian; S Sadi Raza; Ray E Keller
Journal: Pharmacotherapy Date: 2012-04-09 Impact factor: 4.705

6. Dabigatran can cause eosinophilic pleural and pericardial effusion with blood eosinophilia.

Authors: Thanasis Voulgaris; Stavros Anevlavis; Georgia Karpathiou; Fabien Forest; Andreas Koulelidis; Marios Froudarakis
Journal: Clin Respir J Date: 2016-08-08 Impact factor: 2.570

7. Dabigatran versus warfarin in patients with atrial fibrillation.

Authors: Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal: N Engl J Med Date: 2009-08-30 Impact factor: 91.245